Mymetics Corp (MYMX)

[Work Harder]

Peripherally Administered Nanoparticles Target Monocytic Myeloid Cells, Secondary Lymphoid Organs and Tumors in Mice

Toon Stegmann

Jeffrey A. Hubbell

Melody A. Swartz

This study was partly funded by Carigest SA. Toon Stegmann is employed by Mymetics BV. The EPFL has filed for patent protection on the nano particles described. There are no further patents products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Contributed reagents/materials/analysis tools: ICK SH AdT TS

Funding: This study was funded by the Bill and Melinda Gates Foundation (to JAH and MAS), Carigest SA (to MAS), Oncosuisse (to MAS), and the European Research Council project NanoImmune (to JAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

All chemicals were reagent grade and purchased from Sigma-Aldrich (Saint Louis, MO) unless otherwise noted. Antibodies for flow cytometry were purchased from eBioscience (San Diego, CA)

https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0061646

clone BM8, diluted 1/66; eBioscience, catalogue number 25-4801-82

(clone LN3 diluted 1/50; eBiosciences catalogue number 47995642)

https://www.nature.com/articles/s41541-020-0190-9

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158994802

CARIGEST SA

Council in Geneva, Switzerland

Rue de l'Athénée 24, 1206 Genève, Switzerland

http://www.carigest.ch/

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158830753

https://www.google.com/maps/dir/La+Maison+de+l'Horlogerie+SA,+Rue+du+Cendrier+24,+1201+Gen%C3%A8ve,+Switzerland/CARIGEST+SA,+Rue+de+l'Ath%C3%A9n%C3%A9e+24,+1206+Gen%C3%A8ve,+Switzerland/@46.2015414,6.1417012,16z/data=!3m1!4b1!4m13!4m12!1m5!1m1!1s0x478c6599ebfc0bbb:0x7debaa4ae7c6ca5b!2m2!1d6.1454277!2d46.2074682!1m5!1m1!1s0x478c7acd1a7aad6b:0x4154735795896be6!2m2!1d6.1525705!2d46.1955375

Yah, I'd say Texas Pete knows a thing or two

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159066231

I bet Toon & team never sleeps as well

Furthermore, the particles are in liquid form and do not require refrigeration, making this vaccination methodology easily applicable in the developing world.

LOL